X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (73) 73
index medicus (43) 43
female (41) 41
cytomegalovirus infections - immunology (39) 39
cytomegalovirus - immunology (38) 38
adult (37) 37
cytomegalovirus (31) 31
cytomegalovirus infections - virology (29) 29
human cytomegalovirus (29) 29
virology (28) 28
cytomegalovirus infections (27) 27
male (26) 26
immunology (25) 25
pregnancy (24) 24
monoclonal-antibodies (23) 23
cd4-positive t-lymphocytes - immunology (20) 20
middle aged (20) 20
viruses (20) 20
cd8-positive t-lymphocytes - immunology (19) 19
infectious diseases (19) 19
disease (18) 18
infections (18) 18
t cells (18) 18
adolescent (17) 17
cytomegalovirus - genetics (17) 17
cytomegalovirus infections - diagnosis (17) 17
dna, viral - blood (17) 17
transplantation (17) 17
viral load (17) 17
microbiology (16) 16
health aspects (15) 15
infection (15) 15
pp65 antigenemia (15) 15
antiviral agents - therapeutic use (14) 14
blood (14) 14
dendritic cells (14) 14
child (13) 13
cytomegalovirus infections - drug therapy (13) 13
pregnant women (13) 13
simultaneous quantification (13) 13
cytomegalovirus - isolation & purification (12) 12
cytomegalovirus infections - prevention & control (12) 12
preemptive therapy (12) 12
transplant recipients (12) 12
virus diseases (12) 12
cd4 (11) 11
child, preschool (11) 11
ganciclovir (11) 11
polymorphonuclear leukocytes (11) 11
pregnancy complications, infectious - immunology (11) 11
viremia (11) 11
young adult (11) 11
aged (10) 10
cytomegalovirus infections - transmission (10) 10
hematopoietic stem cell transplantation (10) 10
immunity (10) 10
infant (10) 10
infectious disease transmission, vertical (10) 10
kinetics (10) 10
lymphocytes (10) 10
prevention (10) 10
risk factors (10) 10
antibodies (9) 9
antibodies, viral - blood (9) 9
hcmv (9) 9
pregnancy complications, infectious - virology (9) 9
antigens, viral - blood (8) 8
cd4 antigen (8) 8
enzyme-linked immunosorbent assay (8) 8
hematology (8) 8
organ transplantation - adverse effects (8) 8
peripheral-blood (8) 8
primary infection (8) 8
recipients (8) 8
retrospective studies (8) 8
time factors (8) 8
antibodies, viral - immunology (7) 7
cd4 lymphocyte count (7) 7
cd4-positive t-lymphocytes - virology (7) 7
cd8 antigen (7) 7
cd8-positive t-lymphocytes - virology (7) 7
cmv infection (7) 7
cytomegalovirus infections - congenital (7) 7
disease transmission (7) 7
dna (7) 7
fetus (7) 7
flow cytometry (7) 7
infant, newborn (7) 7
lymphocytes t (7) 7
neutralizing antibodies (7) 7
physiological aspects (7) 7
polymerase-chain-reaction (7) 7
primary hcmv infection (7) 7
surgery (7) 7
t-cell response (7) 7
t-lymphocytes - immunology (7) 7
antibodies, neutralizing - blood (6) 6
antibodies, neutralizing - immunology (6) 6
antiviral agents (6) 6
blood polymorphonuclear leukocytes (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Methods in Molecular Biology, ISSN 1064-3745, 04/2016, Volume 1403, pp. 167 - 186
Identification of the most relevant protective antigens has represented a considerable obstacle for the development of subunit vaccines against viral... 
Non-neutralizing | Virus | Screening | Subunit vaccine | Neutralizing | Human monoclonal antibodies | Viral antigens | Vaccines, Subunit - immunology | Animals | B-Lymphocytes - immunology | Cytomegalovirus Vaccines - immunology | Humans | Antibodies, Monoclonal - immunology
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2013, Volume 8, Issue 3, p. e59863
Primary human cytomegalovirus (HCMV) infections during pregnancy are associated with a high risk of virus transmission to the fetus. To identify correlates of... 
RESPONSES | POLYMORPHONUCLEAR LEUKOCYTES | VIRUS | HCMV | MULTIDISCIPLINARY SCIENCES | ENDOTHELIAL-CELLS | MONOCLONAL-ANTIBODIES | CMV | UL131-128 GENES | FIBROBLASTS | PREGNANCY | Pregnancy Complications, Infectious - virology | Immunoglobulin G - blood | Humans | Viral Proteins - immunology | Neutralization Tests | Cytomegalovirus Infections - immunology | Antibodies, Viral - blood | Pregnancy Complications, Infectious - immunology | Antibodies, Neutralizing - immunology | Immunity, Humoral | Immunoglobulin G - immunology | Female | Cytomegalovirus Infections - transmission | Membrane Glycoproteins - immunology | Epithelial Cells - cytology | Binding, Competitive | Cytomegalovirus | Enzyme-Linked Immunosorbent Assay | Infectious Disease Transmission, Vertical | Pregnancy | Regression Analysis | Glycoproteins - immunology | Protein Binding | Antibodies, Viral - immunology | Viral Envelope Proteins - immunology | Antibodies, Neutralizing - blood | Infection | Viral antibodies | Disease transmission | Communications equipment | Pregnant women | Antibodies | Cytomegalovirus infections | Glycoproteins | Health aspects | Epithelial cells | Viruses | Infections | Vaccines | Leukocytes | Immunity | Cell spreading | Antibody response | Granulocytes | Lymphocytes | Fibroblasts | Antigens | Immunoglobulins | Blood & organ donations | Fetuses | Glycoprotein | Risk reduction | Endothelial cells | White blood cells | Hypotheses | Neutralizing | Cell migration
Journal Article
Journal of Clinical Immunology, ISSN 0271-9142, 12/2012, Volume 32, Issue 6, pp. 1324 - 1331
Recently, human cytomegalovirus (HCMV) UL128-131 locus gene products have been found to be associated with glycoprotein H (gH) and glycoprotein L (gL) to form... 
Medical Microbiology | epitopes | Biomedicine | Immunology | Infectious Diseases | Internal Medicine | neutralizing antibodies | pentamer complex | protection | virus dissemination | Human cytomegalovirus | POLYMORPHONUCLEAR LEUKOCYTES | MANAGEMENT | PREEMPTIVE THERAPY | TRANSPLANT RECIPIENTS | IMMUNOLOGY | FIBROBLASTS | RESPONSES | ENDOTHELIAL-CELLS | DISEASE | INFECTION | MONOCLONAL-ANTIBODIES | Coculture Techniques | Humans | Protein Multimerization | Viral Proteins - immunology | Neutralization Tests | Cytomegalovirus Infections - immunology | Antibodies, Viral - blood | Antibodies, Monoclonal - blood | Epitopes - immunology | Leukocytes - immunology | Antibodies, Neutralizing - immunology | Cytomegalovirus Infections - virology | Female | Cytomegalovirus Infections - transmission | Membrane Glycoproteins - immunology | Endothelial Cells - virology | Antibodies, Monoclonal - immunology | Binding, Competitive | Viral Envelope Proteins - genetics | Enzyme-Linked Immunosorbent Assay | Viral Plaque Assay | Viral Proteins - genetics | Biomarkers - blood | Infectious Disease Transmission, Vertical | Epitopes - genetics | Membrane Glycoproteins - genetics | Endothelial Cells - immunology | Pregnancy | Cytomegalovirus - immunology | Leukocytes - virology | Antibodies, Viral - immunology | Viral Envelope Proteins - immunology | Antibodies, Neutralizing - blood | Antigen-antibody reactions | Virus diseases | Monoclonal antibodies | Cytomegalovirus infections | Health aspects | Enzyme-linked immunosorbent assay | Antigenic determinants | Cell migration
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 12/2014, Volume 111, Issue 50, pp. 17965 - 17970
Journal Article
Immunotherapy, ISSN 1750-743X, 01/2016, Volume 8, Issue 9, pp. 1135 - 1135
Human cytomegalovirus (HCMV) represents the major viral complication after hematopoietic stem cell transplantation. HCMV infection may be controlled by the... 
Journal Article
Journal Article
Immunotherapy, ISSN 1750-743X, 09/2016, Volume 8, Issue 9, pp. 1135 - 1149
Human cytomegalovirus (HCMV) represents the major viral complication after hematopoietic stem cell transplantation. HCMV infection may be controlled by the... 
hematopoietic stem cell transplantation | immune reconstitution | pre-emptive therapy | human cytomegalovirus | PERIPHERAL-BLOOD | IMMUNOLOGY | GUIDING PREEMPTIVE THERAPY | LOW-DOSE VALGANCICLOVIR | ALLOGENEIC BONE-MARROW | POLYMERASE-CHAIN-REACTION | INTRAVENOUS IMMUNE GLOBULIN | VIRAL-LOAD | CMV INFECTION | T-CELLS | ORAL VALGANCICLOVIR | Cytosine - analogs & derivatives | Ribonucleosides - therapeutic use | Immunotherapy - methods | Humans | Monitoring, Immunologic | Pneumonia - prevention & control | Postoperative Complications - prevention & control | Cytomegalovirus Infections - complications | Cytomegalovirus Infections - immunology | Asymptomatic Diseases | Postoperative Complications - immunology | Pneumonia - immunology | Adult | Acetates - therapeutic use | Cytosine - therapeutic use | Gastroenteritis - immunology | Benzimidazoles - therapeutic use | Pneumonia - etiology | Organophosphonates - therapeutic use | Antiviral Agents - therapeutic use | Hematopoietic Stem Cell Transplantation | Clinical Trials as Topic | Gastroenteritis - prevention & control | Cytomegalovirus - immunology | Animals | Quinazolines - therapeutic use | Gastroenteritis - etiology | Disease Management | Drugs | Antigens | Cytomegalovirus | Pneumonia | Immunoglobulins | Transplants & implants | Disease | Gastroenteritis | Mortality | Stem cell transplantation | Immune reconstitution | Infections | Vaccines | Hematopoietic stem cells | Hemopoiesis | Immunology | Surveillance | Lymphocytes | Stem cells | Health risk assessment | Immune system
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2012, Volume 7, Issue 7, p. e41648
Journal Article
Journal Article
Journal Article